Results 1 to 10 of about 98,362 (270)

Gonadotropin-Releasing Hormone in Milk [PDF]

Science, 1977
The hypothalamic hormone gonadotropin-releasing hormone (GnRH) has been found in milk of man, cow, and rat. Radioimmunoassays of acidified milk indicate concentrations of GnRH ranging between 0.1 and 3 nanograms per milliliter. Multistep extractions, followed by electrophoresis, reveal gonadotropin-releasing activity in the fraction that comigrates ...
Baram, Tallie, Koch, Yitzhak, Hazum, Eli, Fridkin, Mati   +3 more
openaire   +6 more sources

Pituitary Apoplexy Following Gonadotropin‐Releasing Hormone Agonist Administration for Prostate Cancer [PDF]

IJU Case Reports
Introduction Pituitary apoplexy represents an uncommon endocrine emergency with potentially life‐threatening consequences. Gonadotropin‐releasing hormone agonist used for prostate cancer has the potential to induce pituitary apoplexy, particularly in the
Masaaki Fujimura, Takahiro Shimizu, Shinichi Sakamoto, Hiroaki Sato, Hiroyoshi Suzuki, Kazuo Mikami   +5 more
doaj   +2 more sources

A regulator of G Protein signaling, RGS3, inhibits gonadotropin-releasing hormone (GnRH)-stimulated luteinizing hormone (LH) secretion

BMC Cell Biology, 2001
Background Luteinizing hormone secreted by the anterior pituitary gland regulates gonadal function. Luteinizing hormone secretion is regulated both by alterations in gonadotrope responsiveness to hypothalamic gonadotropin releasing hormone and by ...
Musgrove Lois C, Sellers Jeffrey C, Duck L Wayne, Neill Jimmy D, Kehrl John H   +4 more
doaj   +2 more sources

Gonadotropin-releasing hormone antagonists [PDF]

Current Opinion in Pharmacology, 2003
Hypothalamic gonadotropin-releasing hormone (GnRH) is a decapeptide that stimulates pituitary synthesis and secretion of gonadotropins and, therefore, gonadal hormones. GnRH antagonists, of which thousands have been formulated, inhibit the hormone from binding to its receptor, inducing a pharmacological hypophysectomy.
Herbst, Karen L.
openaire   +3 more sources

Suppression of reproductive function in juvenile rams by a slow-release gonadotropin-releasing hormone implant [PDF]

Open Veterinary Journal, 2022
Background: Regarding animal welfare and reversible suppression of reproduction the need for alternatives to surgical castration like slow-release gonadotropin-releasing hormone implants is increasing.
Luise Prestel, Jessica Joerling, Klaus Failing, Henrik Wagner, Axel Wehrend   +4 more
doaj   +1 more source

Invitro fertilization outcome in triggering with GnRH agonist, Hcg or combination of GnRH agonist and Hcg [PDF]

Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2020
Introduction: Human chorionic gonadotropin for the final maturation of eggs in the In-vitro fertilization cycle was associated with the possibility of a negative effect on endometrial acceptance, fetal quality and ovarian hyper stimulation syndrome ...
Alamtaj Samsami, Sara Davoodi, Shaghayegh Moradi Alamdarloo, Tahere Poordast, Zahra Shiravani, Azade Morshedzadeh   +5 more
doaj   +1 more source

Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious puberty [PDF]

Annals of Pediatric Endocrinology & Metabolism, 2021
Purpose There are few reports on the therapeutic effects of gonadotropin-releasing hormone agonists in boys with central precocious puberty, and studies reported in Korea are very rare.
Ah Young Cho, Su Yeong Ko, Jae Hee Lee, Eun Young Kim   +3 more
doaj   +1 more source

Gonadotropin‐releasing hormone [PDF]

The FEBS Journal, 2008
link_to_subscribed_fulltext
Zvi Naor, Rony Seger
openaire   +4 more sources

Research progress of manganese exposure on abnormal GnRH release in hypothalamus affecting reproductive function

环境与职业医学, 2023
Manganese plays an important physiological role in the organism, and excessive manganese exposure can cause impairment of neurological and reproductive functions.
Huan MAO, Yan LI
doaj   +1 more source

Obstetric and neonatal outcomes after programmed frozen embryo transfer with or without GnRH agonist for polycystic ovary syndrome: secondary analysis results from a randomized controlled trialAJOG Global Reports at a Glance

AJOG Global Reports, 2023
BACKGROUND: Recent studies have reported higher risks of adverse maternal and neonatal outcomes, such as hypertensive disorders of pregnancy, after programmed frozen embryo transfer, especially in cycles with gonadotropin-releasing hormone agonist ...
Hui-ying Jie, MD, Ruifang Hu, BS, Limei Zhang, MD, Kexin Dong, MD, Chunyan Wu, MD, Qiong Wang, MD, Lu Luo, MD   +6 more
doaj   +1 more source